Search

Search Constraints

You searched for: Author/Creator Lynch, Erica Nicola

Search Results

1. Effectiveness and Safety of Nonmedical Switch From Adalimumab Originator to SB5 Biosimilar in Patients With Inflammatory Bowel Diseases: Twelve-Month Follow-Up From the TABLET Registry. Issue 1 (11th February 2021)

2. Effectiveness and Safety of Nonmedical Switch From Adalimumab Originator to SB5 Biosimilar in Patients With Inflammatory Bowel Diseases: Twelve-Month Follow-Up From the TABLET Registry. Issue 1 (5th January 2022)

3. Hepatitis C virus eradication with direct‐acting antiviral improves insulin resistance. Issue 2 (2nd December 2019)

4. Increased Risk of Liver Cirrhosis during Azathioprine Therapy for Crohn's Disease. (29th January 2020)

5. Pregnancy outcomes in inflammatory bowel disease: Data from a large cohort survey. Issue 8 (31st October 2022)

6. Stevens–Johnson Syndrome and Herpes Simplex Type 1 Infection during Adalimumab Therapy for Crohn's Disease. (15th April 2020)